Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Contribution of the vascular bone marrow niche to leukemia progression

Contribution of the vascular bone marrow niche to leukemia progression Leukemia arises from leukemic stem cells, which reside within the bone marrow occupying two different stem cells niches: the endosteal and the vascular niche. The maintenance of leukemic stem cells requires complex regulation mediated by many intrinsic and extrinsic signals provided by their niche cells. The interaction of leukemic and endothelial cells can occur either via direct contact through cell adhesion molecules such as selectins or integrins or signals can be transmitted by chemokines or cytokines of which stromal cell-derived factor 1 represents the most studied. Experimental studies provide evidence that targeting molecules involved in the interaction of leukemic and endothelial cells might represent a promising therapeutic target. Indeed, first clinical trials considering this concept are currently under investigation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Contribution of the vascular bone marrow niche to leukemia progression

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/contribution-of-the-vascular-bone-marrow-niche-to-leukemia-progression-s9XSsbZiHQ
Publisher
Springer Journals
Copyright
Copyright © 2014 by Springer-Verlag Wien
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-014-0149-5
Publisher site
See Article on Publisher Site

Abstract

Leukemia arises from leukemic stem cells, which reside within the bone marrow occupying two different stem cells niches: the endosteal and the vascular niche. The maintenance of leukemic stem cells requires complex regulation mediated by many intrinsic and extrinsic signals provided by their niche cells. The interaction of leukemic and endothelial cells can occur either via direct contact through cell adhesion molecules such as selectins or integrins or signals can be transmitted by chemokines or cytokines of which stromal cell-derived factor 1 represents the most studied. Experimental studies provide evidence that targeting molecules involved in the interaction of leukemic and endothelial cells might represent a promising therapeutic target. Indeed, first clinical trials considering this concept are currently under investigation.

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Jun 13, 2014

References

  • Stem cell concepts renew cancer research
    Dick, JE
  • The vascular niche: home for normal and malignant hematopoietic stem cells
    Doan, PL; Chute, JP.
  • Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
    Fiedler, W; Graeven, U; Ergun, S; Verago, S; Kilic, N; Stockschlader, M
  • Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
    Aguayo, A; Kantarjian, H; Manshouri, T; Gidel, C; Estey, E; Thomas, D
  • Bone marrow stromal cell changes in haematological malignancies
    Dilly, SA; Jagger, CJ.
  • Leukemia stem cells and microenvironment: biology and therapeutic targeting
    Konopleva, MY; Jordan, CT.
  • The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
    Mohle, R; Bautz, F; Rafii, S; Moore, MA; Brugger, W; Kanz, L.
  • Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia
    Rombouts, EJ; Pavic, B; Lowenberg, B; Ploemacher, RE.
  • CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment
    Juarez, J; Dela Pena, A; Baraz, R; Hewson, J; Khoo, M; Cisterne, A
  • Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells
    Liesveld, JL; Bechelli, J; Rosell, K; Lu, C; Bridger, G; Phillips, G
  • Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
    Zeng, Z; Shi, YX; Samudio, IJ; Wang, RY; Ling, X; Frolova, O
  • AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments
    Stamatopoulos, B; Meuleman, N; De Bruyn, C; Pieters, K; Mineur, P; Le Roy, C
  • Identification of Novel Surface Markers and Targets in Neoplastic Stem Cells in AML and CML: a Flow-Gene-Flow Screen Approach
    Herrmann, H; Cerny-Reiterer, S; Sadovnik, I; Winter, V; Blatt, K; Rabitsch, W
  • Robo4 cooperates with CXCR4 to specify hematopoietic stem cell localization to bone marrow niches
    Smith-Berdan, S; Nguyen, A; Hassanein, D; Zimmer, M; Ugarte, F; Ciriza, J
  • Dynamic expression of the Robo ligand Slit2 in bone marrow cell populations
    Smith-Berdan, S; Schepers, K; Ly, A; Passegue, E; Forsberg, EC.
  • Hematopoietic stem cells are coordinated by the molecular cues of the endosteal niche
    ter Huurne, M; Figdor, CG; Torensma, R.
  • Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1
    Mazo, IB; Gutierrez-Ramos, JC; Frenette, PS; Hynes, RO; Wagner, DD; Andrian, UH.
  • Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance
    Winkler, IG; Barbier, V; Nowlan, B; Jacobsen, RN; Forristal, CE; Patton, JT
  • Leukemia mediated endothelial cell activation modulates leukemia cell susceptibility to chemotherapy through a positive feedback loop mechanism
    Pezeshkian, B; Donnelly, C; Tamburo, K; Geddes, T; Madlambayan, GJ.
  • Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche
    Krause, DS; Lazarides, K; Lewis, JB; Andrian, UH; Van Etten, RA.
  • E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model
    Wicklein, D; Schmidt, A; Labitzky, V; Ullrich, S; Valent, P; Schumacher, U.
  • Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis
    Avecilla, ST; Hattori, K; Heissig, B; Tejada, R; Liao, F; Shido, K
  • Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions
    Williams, DA; Rios, M; Stephens, C; Patel, VP.
  • Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
    Rettig, MP; Ansstas, G; DiPersio, JF.
  • Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia
    Matsunaga, T; Takemoto, N; Sato, T; Takimoto, R; Tanaka, I; Fujimi, A
  • Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia
    Magyarosy, E; Sebestyen, A; Timar, J.
  • Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells
    Zarcone, D; De Rossi, G; Tenca, C; Marroni, P; Mauro, FR; Cerruti, GM
  • Targeting of CD44 eradicates human acute myeloid leukemic stem cells
    Jin, L; Hope, KJ; Zhai, Q; Smadja-Joffe, F; Dick, JE.
  • Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia
    Charrad, RS; Li, Y; Delpech, B; Balitrand, N; Clay, D; Jasmin, C
  • Clinical experience with antiangiogenic therapy in leukemia
    Wellbrock, J; Fiedler, W.